Table 7.
Description of patients with invasive aspergillosis.
| Diagnostic Criteria | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patient | Histopathologic Examination |
Clinical Symptoms |
Radiological Abnormalities |
Culture | Galactomannan in BALF | PCR in Blood and BALF | Fungal Co-Infection | Time to Diagnosis (Day) |
Time of Death (Day) |
| 1 | ● | ● | ● | Candida dubliensis | 43 | 57 | |||
| 2 | ● | ● | ● | ● | Candida orthopsilosis *, Candida krusei *, Mucor circinelloides | 78 | 110 | ||
| 3 | ● | ● | ● | Candida glabrata | 36 | 43 | |||
| 4 | ● | ● | ● | ● | ● | Fusarium spp., Penicillium spp. | 26 | 29 | |
| 5 | ● | ● | ● | ● | ● | ● | - | 9 | 15 |
* Possible infection. Abbreviations: BALF: bronchoalveolar lavage fluid; PCR: polymerase chain reaction.